Contact details
Tel +64 4 918 6630
Email jeremy.krebs@otago.ac.nz
Research
Dr Jeremy Krebs is an Endocrinologist and Clinical Leader of Endocrinology and Diabetes at Capital and Coast District Health Board, where he heads the research group. He is also a Professor at the University of Otago, Wellington, and part of the Edgar Diabetes and Obesity Research Centre.
His MD thesis examined the association between obesity and insulin resistance, immersing him in both large intervention studies and small detailed physiological studies, using multiple techniques to measure body composition, insulin sensitivity, and other physiological parameters.
Jeremy continues to develop research projects in both areas, with a particular focus on the association between obesity and type 2 diabetes, both from an aetiology and management perspective.
Inaugural Professorial Lecture
On Wednesday, 12 June 2019 Professor Jeremy Krebs gave his Inaugural Professorial lecture (IPL) on ‘From haggis to hāngi: Are we what we eat?’.
Publications
Vitz, M., Moss, B., Ward, H., Soma, P., Isichei-Kizito, J., Hall, R., & Krebs, J. (2020). New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: An audit of proposed PHARMAC criteria compared with international guidelines. New Zealand Medical Journal, 133(1523), 76-86. Retrieved from https://www.nzma.org.nz/journal
Signal, V., McLeod, M., Stanley, J., Stairmand, J., Sukumaran, N., Thompson, D.-M., Henderson, K., Davies, C., Krebs, J., Dowell, A., Grainger, R., & Sarfati, D. (2020). A mobile- and web-based health intervention program for diabetes and prediabetes self-management (BetaMe/Melon): Process evaluation following a randomized controlled trial. Journal of Medical Internet Research, 22(12), e19150. doi: 10.2196/19150
Wilson, J., Docherty, P., Stubbs, R., Chase, J., & Krebs, J. (2020). Assessment of the Dynamic Insulin Secretion and Sensitivity Test (DISST) pre and post gastric bypass surgery. Experimental Clinical Endocrinology & Diabetes, 128(3), 164-169. doi: 10.1055/a-0603-3539
Scholtens, E. L., Krebs, J. D., Corley, B. T., & Hall, R. M. (2020). Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition? Clinical Nutrition, 39, 3354-3360. doi: 10.1016/j.clnu.2020.02.022
Li, Y., Woods, K., Parry-Strong, A., Anderson, R. J., Capistrano, C., Gestin, A., … Krebs, J., & Gasser, O. (2020). Distinct dysfunctional states of circulating innate-like T cells in metabolic disease. Frontiers in Immunology, 11, 448. doi: 10.3389/fimmu.2020.00448
Chapter in Book - Other
Krebs, J., & Jebb, S. (2005). Dietary factors and insulin resistance. In S. Kumar & S. O'Rahilly (Eds.), Insulin resistance: Insulin action and its disturbances in disease. (pp. 297-316). Chichester, UK: John Wiley & Sons. doi: 10.1002/0470011327
Journal - Research Article
Vitz, M., Moss, B., Ward, H., Soma, P., Isichei-Kizito, J., Hall, R., & Krebs, J. (2020). New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: An audit of proposed PHARMAC criteria compared with international guidelines. New Zealand Medical Journal, 133(1523), 76-86. Retrieved from https://www.nzma.org.nz/journal
Li, Y., Woods, K., Parry-Strong, A., Anderson, R. J., Capistrano, C., Gestin, A., … Krebs, J., & Gasser, O. (2020). Distinct dysfunctional states of circulating innate-like T cells in metabolic disease. Frontiers in Immunology, 11, 448. doi: 10.3389/fimmu.2020.00448
Scholtens, E. L., Krebs, J. D., Corley, B. T., & Hall, R. M. (2020). Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition? Clinical Nutrition, 39, 3354-3360. doi: 10.1016/j.clnu.2020.02.022
Wilson, J., Docherty, P., Stubbs, R., Chase, J., & Krebs, J. (2020). Assessment of the Dynamic Insulin Secretion and Sensitivity Test (DISST) pre and post gastric bypass surgery. Experimental Clinical Endocrinology & Diabetes, 128(3), 164-169. doi: 10.1055/a-0603-3539
Signal, V., McLeod, M., Stanley, J., Stairmand, J., Sukumaran, N., Thompson, D.-M., Henderson, K., Davies, C., Krebs, J., Dowell, A., Grainger, R., & Sarfati, D. (2020). A mobile- and web-based health intervention program for diabetes and prediabetes self-management (BetaMe/Melon): Process evaluation following a randomized controlled trial. Journal of Medical Internet Research, 22(12), e19150. doi: 10.2196/19150
McLeod, M., Stanley, J., Signal, V., Stairmand, J., Thompson, D., Henderson, K., Davies, C., Krebs, J., Dowell, A., Grainger, R., & Sarfati, D. (2020). Impact of a comprehensive digital health programme on HbA1c and weight after 12 months for people with diabetes and prediabetes: A randomised controlled trial. Diabetologia. Advance online publication. doi: 10.1007/s00125-020-05261-x
Zhao, M.-M., Krebs, J., Cao, X., Cui, J., Chen, D.-N., Li, Y., … Mann, J., & Yang, J.-K. (2019). Helicobacter pylori infection as a risk factor for serum bilirubin change and less favourable lipid profiles: A hospital-based health examination survey. BMC Infectious Diseases, 19, 157. doi: 10.1186/s12879-019-3787-8
Teng, A., Blakely, T., Scott, N., Jansen, R., Masters-Awatere, B., Krebs, J., & Oetzel, J. (2019). What protects against pre-diabetes progressing to diabetes? Observational study of integrated health and social data. Diabetes Research & Clinical Practice, 148, 119-129. doi: 10.1016/j.diabres.2018.12.003
McTavish, L., Corley, B., Weatherall, M., Wiltshire, E., & Krebs, J. D. (2018). Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: A randomized crossover clinical trial. Diabetic Medicine, 35(3), 339-346. doi: 10.1111/dme.13576
Gaffney, K. A., Lucero, A., Stoner, L., Faulkner, J., Whitfield, P., Krebs, J., & Rowlands, D. S. (2018). Nil whey protein effect on glycaemic control after intense mixed-mode training in Type 2 diabetes. Medicine & Science in Sports & Exercise, 50(1), 11-17. doi: 10.1249/mss.0000000000001404
Delahunt, J. W., Denison, H. J., Sim, D. A., Bullock, J. J., & Krebs, J. D. (2018). Increasing rates of people identifying as transgender presenting to Endocrine Services in the Wellington region. New Zealand Medical Journal, 131(1468), 33-42. Retrieved from https://www.nzma.org.nz/journal
Redondo, M. J., Geyer, S., Steck, A. K., Sharp, S., Wentworth, J. M., Weedon, M. N., … and Type 1 Diabetes TrialNet Study Group, including Wiltshire, E., & Krebs, J. (2018). A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care, 41(9), 1887-1894. doi: 10.2337/dc18-0087
Othman, N. A., Docherty, P. D., Krebs, J. D., Bell, D. A., & Chase, J. G. (2018). The need to calculate target glucose levels when measuring changes in insulin sensitivity during interventions for individuals with type 2 diabetes. Journal of Diabetes Science & Technology, 12(3), 665-672. doi: 10.1177/1932296817750402
Corley, B. T., Carroll, R. W., Hall, R. M., Weatherall, M., Parry-Strong, A., & Krebs, J. D. (2018). Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: A randomized controlled trial. Diabetic Medicine, 35(5), 588-594. doi: 10.1111/dme.13595
Krebs, J. D., Weatherall, M., Corley, B., Wiltshire, E., & McTavish, L. (2018). Optimizing the management of hypoglycaemia in individuals with type 2 diabetes: A randomized crossover comparison of a weight-based protocol compared with two fixed-dose glucose regimens. Diabetes, Obesity & Metabolism, 20(5), 1256-1261. doi: 10.1111/dom.13231
Boyle, L., Grainger, R., Hall, R. M., & Krebs, J. D. (2017). Use of and beliefs about mobile phone apps for diabetes self-management: Surveys of people in a hospital diabetes clinic and diabetes health professionals in New Zealand. JMIR mHealth & uHealth, 5(6), e85. doi: 10.2196/mhealth.7263
Gamble, E., Parry-Strong, A., Coppell, K. J., McBain, L., Bingham, L. J., Dutton, L., … Krebs, J. D. (2017). Development of a structured diabetes self-management education program specific to the cultural and ethnic population of New Zealand. Nutrition & Dietetics, 74(4), 415-422. doi: 10.1111/1747-0080.12148
van Wissen, K., Thunders, M., Mcbride-Henry, K., Ward, M., Krebs, J., & Page, R. (2017). Cardiovascular disease and prediabetes as complex illness: People's perspectives. Nursing Inquiry, 24, e12177. doi: 10.1111/nin.12177
Whitfield, P., Parry-Strong, A., Walsh, E., Weatherall, M., & Krebs, J. D. (2016). The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: An open-label cross-over randomised controlled trial. European Journal of Nutrition, 55(3), 1123-1131. doi: 10.1007/s00394-015-0926-x
Krebs, J. D., Parry Strong, A., Cresswell, P., Reynolds, A. N., Hanna, A., & Haeusler, S. (2016). A randomised trial of the feasibility of a low carbohydrate diet vs standard carbohydrate counting in adults with type 1 diabetes taking body weight into account. Asia Pacific Journal of Clinical Nutrition, 25(1), 78-84. doi: 10.6133/apjcn.2016.25.1.11
Parry Strong, A., Haeusler, S., Weatherall, M., & Krebs, J. (2016). Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with meformin: A randomised trial. New Zealand Medical Journal, 129(1436), 67-75. Retrieved from http://www.nzma.org.nz/journal
Gendall, P., Hoek, J., Taylor, R., Mann, J., Krebs, J., & Parry-Strong, A. (2015). Should support for obesity interventions or perceptions of their perceived effectiveness shape policy? Australian & New Zealand Journal of Public Health, 39(2), 172-176. doi: 10.1111/1753-6405.12319
McEntyre, C. J., Lever, M., Chambers, S. T., George, P. M., Slow, S., Elmslie, J. L., Florkowski, C. M., Lunt, H., & Krebs, J. D. (2015). Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine, and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Annals of Clinical Biochemistry, 52(3), 352-360. doi: 10.1177/0004563214545346
McTavish, L., Krebs, J. D., Weatherall, M., & Wiltshire, E. (2015). Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: A randomized crossover clinical trial. Diabetic Medicine, 32, 1143-1148. doi: 10.1111/dme.12730
Othman, N. A., Docherty, P. D., Krebs, J. D., Bell, D. A., & Chase, J. G. (2015). The necessity of identifying the basal glucose set-point in the IVGTT for patients with Type 2 Diabetes. BioMedical Engineering OnLine, 14(1), 18.
Cresswell, P., Krebs, J., Gilmour, J., Hanna, A., & Parry-Strong, A. (2015). From 'pleasure to chemistry': Yhe experience of carbohydrate counting with and without carbohydrate restriction for people with Type 1 diabetes. Journal of Primary Health Care, 7(4), 291-298.
Lever, M., McEntyre, C. J., George, P. M., Slow, S., Elmslie, J. L., Lunt, H., Chambers, S. T., Parry-Strong, A., & Krebs, J. D. (2014). Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovascular Drugs & Therapy, 28, 459-468. doi: 10.1007/s10557-014-6542-9
Rowlands, D. S., Page, R. A., Sukala, W. R., Giri, M., Ghimbovschi, S. D., Hayat, I., … Leikis, M., Sheard, P. W., Wakefield, St. J., … Krebs, J., … Hoffman, E. P. (2014). Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity. Physiological Genomics, 46(20), 747-765. doi: 10.1152/physiolgenomics.00024.2014
Haeusler, S., Parry-Strong, A., & Krebs, J. D. (2014). The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand: A clinical audit. New Zealand Medical Journal, 127(1404). Retrieved from http://www.nzma.org.nz/journal
Krebs, J. D., Parry-Strong, A., Gamble, E., McBain, L., Bingham, L. J., Dutton, E. S., … Coppell, K. J. (2013). A structured, group-based diabetes self-management education (DSME) programme for people, families and whanau with type 2 diabetes (T2DM) in New Zealand: An observational study. Primary Care Diabetes, 7(2), 151-158. doi: 10.1016/j.pcd.2013.02.002
Krebs, J. D., & Parry-Strong, A. (2013). Is there an optimal diet for patients with type 2 diabetes? Yes, the one that works for them! British Journal of Diabetes & Vascular Disease, 13(2), 60-66. doi: 10.1177/1474651413479040
Sukala, W. R., Page, R., Lonsdale, C., Lys, I., Rowlands, D., Krebs, J., Leikis, M., & Cheema, B. S. (2013). Exercise improves quality of life in indigenous Polynesian peoples with type 2 diabetes and visceral obesity. Journal of Physical Activity & Health, 10(5), 699-707.
Krebs, J. D., Bell, D., Hall, R., Parry-Strong, A., Docherty, P. D., Clarke, K., & Chase, J. G. (2013). Improvements in glucose metabolism and insulin sensitivity with a low-carbohydrate diet in obese patients with type 2 diabetes. Journal of the American College of Nutrition, 32(1), 11-17. doi: 10.1080/07315724.2013.767630
Murphy, R., Carroll, R. W., & Krebs, J. D. (2013). Pathogenesis of the metabolic syndrome: Insights from monogenic disorders. Mediators of Inflammation, 2013, 920214. doi: 10.1155/2013/920214
Carroll, R. W., Hall, R. M., Parry-Strong, A., Wilson, J. M., & Krebs, J. D. (2013). Therapeutic options in the management of obesity. New Zealand Medical Journal, 126(1386). Retrieved from http://www.nzma.org.nz/journal
Parry-Strong, A., Leikis, M., & Krebs, J. D. (2013). High protein diets and renal disease: Is there a relationship in people with type 2 diabetes? British Journal of Diabetes & Vascular Disease, 13(5-6), 238-243. doi: 10.1177/1474651413503020
Krebs, J. D., Parry-Strong, A., Weatherall, M., Carroll, R. W., & Downie, M. (2012). A cross-over study of the acute effects of espresso coffee on glucose tolerance and insulin sensitivity in people with type 2 diabetes mellitus. Metabolism, 61(9), 1231-1237. doi: 10.1016/j.metabol.2012.01.021
Sukala, W. R., Page, R., Rowlands, D. S., Krebs, J., Lys, I., Leikis, M., … Cheema, B. S. (2012). South Pacific Islanders resist type 2 diabetes: Comparison of aerobic and resistance training. European Journal of Applied Physiology, 112(1), 317-325. doi: 10.1007/s00421-011-1978-0
Krebs, J. D., Elley, C. R., Parry-Strong, A., Lunt, H., Drury, P. L., Bell, D. A., … Mann, J. I. (2012). The Diabetes Excess Weight Loss (DEWL) trial: A randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia, 55, 905-914. doi: 10.1007/s00125-012-2461-0
Sukala, W. R., Page, R. A., Rowlands, D. S., Lys, I., Krebs, J. D., Leikis, M. J., & Cheema, B. S. (2012). Exercise intervention in New Zealand Polynesian peoples with type 2 diabetes: Cultural considerations and clinical trial recommendations. Australasian Medical Journal, 5(8), 429-435. doi: 10.4066/amj.2012.1311
Foo, J., Krebs, J., Hayes, M. T., Bell, D., Macartney-Coxson, D., Croft, T., & Stubbs, R. S. (2011). Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery. Obesity Surgery, 21(12), 1914-1920. doi: 10.1007/s11695-011-0527-6
Smith, R., Krebs, J., Weatherall, M., McBain, L., Hullah, M., & Shapleski, M. (2011). Analysis of a primary care led diabetes annual review programme in a multi ethnic cohort in Wellington, New Zealand. Diabetes Research & Clinical Practice, 91(2), 164-170. doi: 10.1016/j.diabres.2010.11.018
Browning, L. M., Krebs, J. D., Magee, E. C., Frühbeck, G., & Jebb, S. A. (2008). Circulating markers of inflammation and their link to indices of adiposity. Obesity Facts, 1(5), 259-265. doi: 10.1159/000169832
Browning, L. M., Krebs, J. D., Siervo, M., Hall, R. M., Finer, N., Allison, M. E., & Jebb, S. A. (2008). Inflammation is associated with liver function markers, independent of other metabolic risk factors in overweight women. British Journal of Diabetes & Vascular Disease, 8, 73-76. doi: 10.1177/14746514080080020401
Browning, L. M., Krebs, J. D., Moore, C. S., Mishra, G. D., O'Connell, M. A., & Jebb, S. A. (2007). The impact of long chain n-3 polyunsaturated fatty acid supplementation of inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes, Obesity & Metabolism, 9, 70-80. doi: 10.1111/j.1463-1326.2006.00576.x
Harding, S. A., Anscombe, R., Weatherall, M., Prasad, S., Lever, N., & Krebs, J. (2006). Abnormal glucose metabolism and features of the metabolic syndrome are common in patients presenting for elective cardiac catheterization. Internal Medicine Journal, 36, 759-764.
Moore, C. S., Bryant, S. P., Mishra, G. D., Krebs, J. D., Browning, L. M., Miller, G. J., & Jebb, S. A. (2006). Oily fish reduces plasma triacylglycerols: A primary prevention study in overweight men and women. Nutrition, 22, 1012-1024. doi: 10.1016/j.nut.2006.07.005
Krebs, J. D., Browning, L. M., McLean, N. K., Rothwell, J. L., Mishra, G. D., Moore, C. S., & Jebb, S. A. (2006). Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. International Journal of Obesity, 30, 1535-1544. doi: 10.1038/sj.ijo.0803309
Browning, L. M., Jebb, S. A., Mishra, G. D., Cooke, J. H., O'Connell, M. A., Crook, M. A., & Krebs, J. D. (2004). Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women. International Journal of Obesity, 28(8), 1004-1010. doi: 10.1038/sj.ijo.0802711
